OncoVista Innovative Therapies, Inc. Stock Other OTC
Equities
OVIT
US68232J1051
Biotechnology & Medical Research
Sales 2013 | - | Sales 2014 | - | Capitalization | 1.3M 1.78M |
---|---|---|---|---|---|
Net income 2013 | -1M -1.37M | Net income 2014 | -2M -2.74M | EV / Sales 2013 | - |
Net cash position 2013 | 44.9K 61.42K | Net Debt 2014 | 196K 268K | EV / Sales 2014 | - |
P/E ratio 2013 |
-0.75
x | P/E ratio 2014 |
-0.51
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | 07-08-15 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |